300 related articles for article (PubMed ID: 16172836)
1. Daily Record of Severity of Problems (DRSP): reliability and validity.
Endicott J; Nee J; Harrison W
Arch Womens Ment Health; 2006 Jan; 9(1):41-9. PubMed ID: 16172836
[TBL] [Abstract][Full Text] [Related]
2. Diagnosing premenstrual dysphoric disorder: the reliability of a structured clinical interview.
Accortt EE; Bismark A; Schneider TR; Allen JJ
Arch Womens Ment Health; 2011 Jun; 14(3):265-7. PubMed ID: 21336934
[TBL] [Abstract][Full Text] [Related]
3. A symptom diary to assess severe premenstrual syndrome and premenstrual dysphoric disorder.
Janda C; Kues JN; Andersson G; Kleinstäuber M; Weise C
Women Health; 2017 Aug; 57(7):837-854. PubMed ID: 27355449
[TBL] [Abstract][Full Text] [Related]
4. Differences in symptom scores and health outcomes in premenstrual syndrome.
Borenstein JE; Dean BB; Leifke E; Korner P; Yonkers KA
J Womens Health (Larchmt); 2007 Oct; 16(8):1139-44. PubMed ID: 17937566
[TBL] [Abstract][Full Text] [Related]
5. Chinese version of Daily Record of Severity of Problems: reliability and validity.
Wu L; He Z; Zhao H; Ma D; Zhang S; Deng H; Liang T
J Adv Nurs; 2013 Feb; 69(2):449-56. PubMed ID: 22737971
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and predictors of premenstrual dysphoric disorder (PMDD) in older premenopausal women. The Harvard Study of Moods and Cycles.
Cohen LS; Soares CN; Otto MW; Sweeney BH; Liberman RF; Harlow BL
J Affect Disord; 2002 Jul; 70(2):125-32. PubMed ID: 12117624
[TBL] [Abstract][Full Text] [Related]
7. Survey of premenstrual symptom severity and impairment in Korean adolescents: premenstrual dysphoric disorder, subthreshold premenstrual dysphoric disorder and premenstrual syndrome.
Yang J; Joe SH; Lee MS; Kim SH; Jung IK
Asia Pac Psychiatry; 2014 Jun; 6(2):135-44. PubMed ID: 23857722
[TBL] [Abstract][Full Text] [Related]
8. Development and validation of the Premenstrual Symptoms Impact Survey (PMSIS): a disease-specific quality of life assessment tool.
Wallenstein GV; Blaisdell-Gross B; Gajria K; Guo A; Hagan M; Kornstein SG; Yonkers KA
J Womens Health (Larchmt); 2008 Apr; 17(3):439-50. PubMed ID: 18328013
[TBL] [Abstract][Full Text] [Related]
9. Explorative evaluation of the impact of severe premenstrual disorders on work absenteeism and productivity.
Heinemann LA; Minh TD; Filonenko A; Uhl-Hochgräber K
Womens Health Issues; 2010; 20(1):58-65. PubMed ID: 20123176
[TBL] [Abstract][Full Text] [Related]
10. Validation of a revised visual analog scale for premenstrual mood symptoms: results from prospective and retrospective trials.
Steiner M; Streiner DL
Can J Psychiatry; 2005 May; 50(6):327-32. PubMed ID: 15999948
[TBL] [Abstract][Full Text] [Related]
11. Premenstrual Syndrome Diagnosis: A Comparative Study between the Daily Record of Severity of Problems (DRSP) and the Premenstrual Symptoms Screening Tool (PSST).
Henz A; Ferreira CF; Oderich CL; Gallon CW; Castro JRS; Conzatti M; Fleck MPA; Wender MCO
Rev Bras Ginecol Obstet; 2018 Jan; 40(1):20-25. PubMed ID: 29132173
[TBL] [Abstract][Full Text] [Related]
12. Establishing the diagnostic validity of premenstrual dysphoric disorder using rasch analysis.
Gehlert S; Chang CH; Hartlage S
J Outcome Meas; 1997; 1(1):2-18. PubMed ID: 9661712
[TBL] [Abstract][Full Text] [Related]
13. A design for studying the DSM-IV research criteria of premenstrual dysphoric disorder.
Gehlert S; Hartlage S
J Psychosom Obstet Gynaecol; 1997 Mar; 18(1):36-44. PubMed ID: 9138205
[TBL] [Abstract][Full Text] [Related]
14. Operationalizing DSM-IV criteria for PMDD: selecting symptomatic and asymptomatic cycles for research.
Smith MJ; Schmidt PJ; Rubinow DR
J Psychiatr Res; 2003; 37(1):75-83. PubMed ID: 12482472
[TBL] [Abstract][Full Text] [Related]
15. Toward the Reliable Diagnosis of DSM-5 Premenstrual Dysphoric Disorder: The Carolina Premenstrual Assessment Scoring System (C-PASS).
Eisenlohr-Moul TA; Girdler SS; Schmalenberger KM; Dawson DN; Surana P; Johnson JL; Rubinow DR
Am J Psychiatry; 2017 Jan; 174(1):51-59. PubMed ID: 27523500
[TBL] [Abstract][Full Text] [Related]
16. How to measure the impact of premenstrual symptoms? Development and validation of the German PMS-Impact Questionnaire.
Kues JN; Janda C; Kleinstäuber M; Weise C
Women Health; 2016 Oct; 56(7):807-26. PubMed ID: 26624615
[TBL] [Abstract][Full Text] [Related]
17. The Iranian version of the Premenstrual Symptoms Screening Tool (PSST): a validation study.
Hariri FZ; Moghaddam-Banaem L; Siah Bazi S; Saki Malehi A; Montazeri A
Arch Womens Ment Health; 2013 Dec; 16(6):531-7. PubMed ID: 23974654
[TBL] [Abstract][Full Text] [Related]
18. Premenstrual dysphoric disorder among medical students of a Nigerian university.
Issa BA; Yussuf AD; Olatinwo AW; Ighodalo M
Ann Afr Med; 2010; 9(3):118-22. PubMed ID: 20710100
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of a unique oral contraceptive (Yasmin) in the management of premenstrual dysphoric disorder.
Freeman EW
Eur J Contracept Reprod Health Care; 2002 Dec; 7 Suppl 3():27-34; discussion 42-3. PubMed ID: 12659404
[TBL] [Abstract][Full Text] [Related]
20. Levetiracetam for treatment of premenstrual dysphoric disorder: a pilot, open-label study.
Kayatekin ZE; Sabo AN; Halbreich U
Arch Womens Ment Health; 2008 Jul; 11(3):207-11. PubMed ID: 18493713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
